Karen A. Foster is Chief Quality and Operations of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 157,291 shares of BLFS, which is worth approximately $3.68 Million. The most recent transaction as insider was on May 27, 2022, when has been sold 174 shares (Common Stock) at a price of $14.53 per share, resulting in proceeds of $2,528. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 157K
0.41% 3M change
25.48% 12M change
Total Value Held $3.68 Million

Karen A. Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 27 2022
SELL
Open market or private sale
$2,528 $14.53 p/Share
174 Reduced 0.16%
107,839 Common Stock
May 22 2022
BUY
Grant, award, or other acquisition
-
533 Added 0.49%
108,013 Common Stock
May 13 2022
SELL
Open market or private sale
$715 $12.32 p/Share
58 Reduced 0.05%
107,480 Common Stock
Apr 18 2022
SELL
Open market or private sale
$288,705 $17.59 p/Share
16,413 Reduced 13.24%
107,538 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
-
38,836 Added 23.86%
123,951 Common Stock
Mar 29 2022
SELL
Open market or private sale
$12,165 $22.24 p/Share
547 Reduced 0.64%
85,115 Common Stock
Mar 01 2022
SELL
Open market or private sale
$5,255 $23.78 p/Share
221 Reduced 0.32%
69,306 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
16,356 Added 16.0%
85,883 Common Stock
Feb 10 2022
SELL
Open market or private sale
$8,608 $29.38 p/Share
293 Reduced 0.42%
69,527 Common Stock
Dec 29 2021
SELL
Open market or private sale
$24,606 $39.37 p/Share
625 Reduced 0.89%
69,820 Common Stock
Nov 30 2021
SELL
Open market or private sale
$11,841 $37.59 p/Share
315 Reduced 0.45%
70,445 Common Stock
Nov 22 2021
SELL
Open market or private sale
$754,375 $46.19 p/Share
16,332 Reduced 18.75%
70,760 Common Stock
Nov 22 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.79%
87,092 Common Stock
Oct 25 2021
SELL
Open market or private sale
$725,957 $44.45 p/Share
16,332 Reduced 18.75%
70,760 Common Stock
Oct 25 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.79%
87,092 Common Stock
Oct 14 2021
SELL
Open market or private sale
$43,248 $39.97 p/Share
1,082 Reduced 1.51%
70,760 Common Stock
Sep 28 2021
SELL
Open market or private sale
$26,303 $43.12 p/Share
610 Reduced 0.84%
71,842 Common Stock
Sep 27 2021
SELL
Open market or private sale
$729,387 $44.66 p/Share
16,332 Reduced 18.4%
72,452 Common Stock
Sep 27 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.54%
88,784 Common Stock
Aug 26 2021
SELL
Open market or private sale
$18,609 $57.26 p/Share
325 Reduced 0.45%
72,452 Common Stock
Aug 23 2021
SELL
Open market or private sale
$760,091 $46.54 p/Share
16,332 Reduced 18.33%
72,777 Common Stock
Aug 23 2021
BUY
Exercise of conversion of derivative security
$26,784 $1.64 p/Share
16,332 Added 15.49%
89,109 Common Stock
Jul 26 2021
SELL
Open market or private sale
$738,905 $45.24 p/Share
16,333 Reduced 18.33%
72,777 Common Stock
Jul 26 2021
BUY
Exercise of conversion of derivative security
$26,786 $1.64 p/Share
16,333 Added 15.49%
89,110 Common Stock
Jun 29 2021
SELL
Open market or private sale
$26,556 $43.75 p/Share
607 Reduced 0.83%
72,777 Common Stock
KAF

Karen A. Foster

Chief Quality and Operations
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS